Novasep Offering for Production and Purification of Biopharmaceuticals

Novasep offers downstream processing solutions for the production of biopharmaceuticals with the following characteristics:

• origin is not from recombinant DNA :
• Vaccines
• Toxins & antibiotics
• Enzymes, hormones & polyclonal antibodies
• Drugs derived from blood
• Cell & tissue therapies
• origin is from recombinant DNA :
• Nucleic acids ( oligonucleotides, plasmid, DNA vaccines, gene therapies)
• Recombinant proteins;
• Therapeutic proteins: growth factors, hormones, cytokines, enzymes, fusion proteins, blood plasma factors
• Monoclonal antibodies (mAbs)
• Therapeutic and recombinant vaccines
• manufacturing process has to be compliant with cGMP
• manufacturing process does not require, in most cases, synthesis steps
• manufacturing process necessitates precautions against microbial contaminations.

Typical Processing for Production  & Purification of Biopharmaceuticals   

Production and Purification of Biopharmaceuticals with Novasep

Novasep owns a unique palette of technologies (preparative LPLC, MPLC, HPLC, SMCC, filtration solutions) developed for Biopharmaceutical production.

Novasep offers innovative and user-friendly products (Chromatography columns & systems, Tangential Flow Filtration (TFF) membranes & systems) for Biopharmaceutical production.

Novasep combines the complementary talents of chemical, electrical and automation engineers as well as chemists to offer its expertise in customized services suited to your expectations.

 

Benefits and Advantages 

Shorten Time to Market 

The biopharmaceutical industry’s objective is to bring new biomolecules to clinical trial more quickly and, therefore, more quickly to commercial scale. Novasep reduces downstream processing development lead-times using computerized modelling tools. At a later stage, these modelling tools allow rapid scale-up with guaranteed results.

Regulatory Compliance

The biopharmaceutical industry cannot compromise when it comes to quality and patient safety. Novasep solutions comply with all regulatory and quality requirements with on-line monitoring. Novasep solutions ensure the highest quality and safety level while optimizing purity and yield.

Novasep has built and runs its own FDA regulated production facilities and can bring pragmatic expertise to all disciplines including facility design, process design and development, as well as regulatory and quality requirements.

Increased Production Capacities

With higher titres, tougher competition and increasingly stringent quality and regulatory requirements, the challenge is to align the efficiency of downstream processing to upstream titres. Novasep solutions offer unique features that help develop the optimum downstream processing to compete with your upstream.